drugset / Trial / NCT00206323
A Randomized, Placebo-controlled, Tourette Syndrome Study.
Phase 3
Completed
29 enrolled
Baylor College of Medicine
Ortho-McNeil Janssen Scientific Affairs, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Previous studies using topiramate in Tourette subjects have shown that with the use of this medication subjects report that their tics get better. The purpose of this study is to study if topiramate improves the symptoms of Tourette syndrome, such as motor tics, or other associated symptoms such as attention or obsessive-compulsive problems.
Timeline
- Start
- 2004-09
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Topiramate | Small molecule | 200 mg | — |